GENEXI combines the expertise of renowned specialists in the biotech industry to create a thriving ecosystem for biotech strartups and established pharmaceutical companies of different sizes and levels of operation.
GENEXI Foundation is an organisation employing a wide range of high-profile biotech professionals to provide manual heuristic analysis for the most detailed venture assessment and evaluation.
GENEXI Foundation will use its expertise and funds to select the most promising biotech startups for grant awarding.
GENEXI Platform is an innovative solution provided by the GENEXI Dev Team for the e-commerce market in order to support GENEXI Ecosystem development. The Platform will unite biotech producers, distributors, retailers and end-consumers in one blockchain-based solution operating as a global ecosystem.
Missing whitepaper? Let us know.
Rated on Jul 4, 2018
Modified on Jul 4, 2018
The biotech industry has a great perspective using blockchain. This team is reinforced and quite numerous. This is a project with a good potential if well implemented. The WP still should be a bit improved as comes to numbers.
Rated on May 19, 2018
The project intend to build transparency ecosystem for biotech and encourage the participation by using token as a media. It's a good direction and I looking forward to see it works.
However, from my many years experience of doing business with biotech, the player in biotech industry is usually very conservation and self-protected.
So, I think the challenge is not technology but how to promote and convincing all player. The core team is strong, but I will recommend invite more channel and sales partner to speed up market adaption.
Rated on May 27, 2018
UPD: Good and big team.
Great vision. And biotech is huge market.
MVP - will soon!
KYC - passed it's good
Vision is good
Need more strong marketing and PR
Rated on May 15, 2018
Great concept a biotech accelerator providing a Blockchain based solution!
Rated on Sep 7, 2018
Modified on Sep 7, 2018
Very interesting product, although this is a very hard ecosystem to break in, as biotech breakthroughs can be very expensive to get. Great team and advisory board. Good luck team!
Rated on May 21, 2018
Nowadays biotech industry is very promising and implementation blockchain technology in it could provide a great competitive advantage to the project.
GENEXI wants to create not just some local solution but a complex product which will help to solve the problem of the supply chain, drug counterfeit, fraud and quality manipulation.
They have a solid and experienced team in the business sphere. Their MVP will be launched in Q3 this year, keep waiting.
Rated on May 24, 2018
In my opinion:
- Good team
- Nice vision
- The fact that the company is registered in Switzerland is a big plus for investors
- The market has high CAGR
Rated on Jun 14, 2018
Team : looks great but when checked linked most of them either dont have it or have few connections.
Vision is good but i think they have to work very hard for it.
Product : cant see any prototype though the website was awesome but cant rate a website.
Experts are independently and voluntarily contributing to the community. If no expert has rated the ICO, only ICO analyzer's results are used. Always research before investing as these ratings should not be taken as an investing guide of any kind.
Ratings and ICO analyzer results are being updated (re-calculated) every few hours.
TeamApply as an advisor
Head of Operations
Head of Strategy
Head of Business Development
Head of HR
Head of Marketing
Head of IT
Technical Support Lead
|Pre-Sale Round, 01.05 - 31.05||20%|
|Token Sale Round 1, 01.06 – 14.06||17%|
|Token Sale Round 2, 15.06 – 05.07||9%|
|Token Sale Round 3, 06.07 – 26.07||5%|
|Token Sale Round 4, 27.07 – 31.08||2%|
Primary Scientific and Medical Research.
Ecosystem and Platform Development.
Low Level Design Launch.
Ecosystem Alpha Version Testing.
Smart-Contract Development and Testing. Grant Application Program Launch.
Ecosystem Complete Version Launch.
Official Public GENEXI Accelerator Report.
Further Ecosystem Development and Scaling.